User contributions
Jump to navigation
Jump to search
- 18:39, 21 October 2024 diff hist +7,072 N NTproANP quantities throughout peripheral and cardiovascular blood flow Created page with "The median treatment period was 19 weeks (range 1-65), an average of 11 doses (range 1-36) were applied. 39 (45.3%) patients developed adverse events, mostly mild, grade I (64..." current